Targeted Enrichment and Characterization of Diester Diterpenoid Alkaloids in Aconitum Herbs Using Gas–Liquid Microextraction Coupled with High-Resolution Mass Spectrometry
Molecules · 2025
DOI: 10.3390/molecules30194029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Yijun Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of…. Hauptthemen laut MEDLINE: Aconitum, Alkaloids, Diterpenes, Liquid Phase Microextraction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China, Scientific and technological innovation project of China Academy of Chinese Medical Sciences.
Abstract (Originalsprache)
Diterpenoid diester alkaloids (DDAs) are the primary toxic constituents in aconite herbs, while also being the key pharmacologically active components. Consequently, establishing rapid enrichment and highly sensitive analytical methods for DDAs is of critical importance. Herein, we developed and constructed a gas–liquid microextraction (GLME) device, which enables the rapid and selective enrichment of DDAs from complex matrices. The enriched extract can be directly analyzed by high-resolution Orbitrap mass spectrometry without requiring any further pretreatment. A comparative analysis of six commonly used Aconitum herbs medicines and their processed derivatives was conducted. Notably, GLME enhanced the mass spectrometric signals of DDAs by 3–4 orders of magnitude, facilitating the identification of 27 alkaloids, including 3 potential new compounds (15-Ethyl-13-deoxyanhydroaconitine, 13-Hydroxy-15-ethylanhydroaconitine and 8-eicosapentaenoic-benzoylmesaconine). It was found that among the tested samples, the DDAs response intensity of raw Caowu was the highest, and the DDA signals decreased significantly after processing. This result chemically validates the detoxification efficacy of traditional methods. The proposed GLME-MS strategy has the advantages of being green, economical, easy to operate, and highly selective (>1000-fold), which provides a technical reference for the rapid detection, safety assessment, and quality control of Aconitum herbs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- Shandong Center for Food and Drug Evaluation & Inspection, Jinan 250014, China.
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Scientific and technological innovation project of China Academy of Chinese Medical Sciences
Zitieren
APA
Wang, Y., Miao, C., Wu, J., Hua, Y., Li, X., Kang, L., & Qiu, Z. (2025). Targeted Enrichment and Characterization of Diester Diterpenoid Alkaloids in Aconitum Herbs Using Gas–Liquid Microextraction Coupled with High-Resolution Mass Spectrometry. Molecules. https://doi.org/10.3390/molecules30194029
Vancouver
Wang Y, Miao C, Wu J, Hua Y, Li X, Kang L, et al. Targeted Enrichment and Characterization of Diester Diterpenoid Alkaloids in Aconitum Herbs Using Gas–Liquid Microextraction Coupled with High-Resolution Mass Spectrometry. Molecules. 2025. doi:10.3390/molecules30194029
BibTeX
@article{Wang2025,
author = {Wang, Yijun and Miao, Ceyu and Wu, Junxian and Hua, Yutong and Li, Xiang and Kang, Liping and Qiu, Zidong},
title = {Targeted Enrichment and Characterization of Diester Diterpenoid Alkaloids in Aconitum Herbs Using Gas–Liquid Microextraction Coupled with High-Resolution Mass Spectrometry},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30194029}
}
EUVIMED